Dennis Cooper, MD

Dennis Cooper, MD, sheds light on the novel therapeutic regimens available to patients with multiple myeloma.

Despite the failure of several strategies to improve the outcomes of patients with newly diagnosed diffuse large B-cell lymphoma, there appears to be substantial and growing progress in the treatment of relapsed disease.